Bromide

Bromide

SCHEMBL1645798

Cc1ccc(F)c[n+]1CC(=O)c1ccccc1.[Br-]

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.58
LMNA P02545 5/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
KMT2A Q03164 8/20 0.50
ALDH1A1 P00352 5/20 0.50
HTT P42858 3/20 0.50
MITF O75030 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
POLB P06746 1/20 0.50
RECQL P46063 1/20 0.49
PABPC1 P11940 1/20 0.49
ATM Q13315 1/20 0.49
MEN1 O00255 3/20 0.47
ALPG P10696 1/20 0.47
HPGD P15428 1/20 0.47
GLA P06280 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2230581 0.98 KDM4E (0.59) KDM4ELMNASMN1; SMN2KMT2AALDH1A1
Bromide SCHEMBL3883521 0.84 KDM4E (0.78) KDM4ELMNASMN1; SMN2KMT2AALDH1A1
Bromide SCHEMBL3888558 0.79 KMT2A (0.67) KDM4ELMNASMN1; SMN2KMT2AALDH1A1
Bromide SCHEMBL3884195 0.79 KMT2A (0.70) KDM4ELMNASMN1; SMN2KMT2AALDH1A1
SCHEMBL4898501 0.78 KMT2A (0.64) KDM4ELMNASMN1; SMN2KMT2AALDH1A1
Bromide SCHEMBL1645919 0.78 KMT2A (0.73) KDM4ELMNASMN1; SMN2KMT2AALDH1A1
SCHEMBL4896174 0.77 KMT2A (0.68) KDM4ESMN1; SMN2KMT2AALDH1A1POLB
SCHEMBL13394254 0.76 KMT2A (0.70) KDM4ELMNASMN1; SMN2KMT2AALDH1A1
Bromide SCHEMBL3883473 0.72 THRB (0.58) KDM4ELMNASMN1; SMN2KMT2AALDH1A1
Bromide SCHEMBL6225621 0.72 KMT2A (0.68) KDM4ELMNAKMT2AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2303329-A1 ANTIFUNGAL COMBINATION THERAPY F2G Limited (GB) 2011-04-06 EP disclosed
WO-2009144473-A1 ANTIFUNGAL COMBINATION THERAPY F2G LIMITED (GB) 2009-12-03 WO disclosed
EP-2097413-A1 2-[(2-SUBSTITUTED)-IND0LIZIN-3-YL]-2-OXO-ACETAMIDE DERIVATIVES AS ANTIFUNGAL AGENTS F2G Limited (GB) 2009-09-09 EP disclosed
WO-2008062182-A1 2- [ (2-SUBSTITUTED) -IND0LIZIN-3-YL] -2-OXO-ACETAMIDE DERIVATIVES AS ANTIFUNGAL AGENTS F2G LTD (GB) 2008-05-29 WO disclosed